4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-001306
Options or other derivatives
- 10% owner acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pontifax Management 4 G.P. (2015) Ltd. · 10% owner
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +20,000 | 20,000 | I |
| 2020-05-20 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +20,000 | 20,000 | I |
Loading xslF345X03/form4-05222020_040544.xml…